Project Details
Description
Project Narrative
Glioblastoma (GBM) is one of the most devastating human cancers that almost always recurs due to the
presence of invasive therapy-resistant infiltrating cancer cells at the tumor margin. Magnetic hyperthermia
therapy (MHT) is a powerful, nanotechnology-based treatment that may enhance the effects of radiation therapy
(RT) and chemotherapy against infiltrating GBM tumors.
Status | Finished |
---|---|
Effective start/end date | 1/12/19 → 30/11/22 |
Funding
- National Cancer Institute: $653,976.00
- National Cancer Institute: $706,027.00
- National Cancer Institute: $619,800.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.